entertainment -WSS

entertainment

author：focus 2025-08-19 20:44:51 - browse：4

Illustration of basket of food with prescription pad — Molly Ferguson for STAT

WASHINGTON — After nearly 40 years of obscurity, the “food is medicine” movement is having a moment.

Multiple federal agencies are working on food is medicine projects, major organizations have pledged hundreds of millions in research funding, and billions more are being invested in food-focused startups. Even the White House has publicly announced its support for the movement, which focuses on the use of healthy food as a medical intervention for certain chronic and diet-related diseases.

“We are at the inflection point,” said Dariush Mozaffarian, the dean for policy at the Tufts Friedman School of Nutrition Science and Policy. “Five or six years ago I would go to major health care organizations and talk about food [is] medicine and I’d get blank stares, crickets, and polite emails.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： The Harvard botanist who searched for psychedelics in the Amazon

WSS

New documents shed light on MD Anderson Cancer Institute feud

Despite FDA concern, risk that CAR

R1 RCM gets $5.8 billion buyout offer from private equity firm

In utero gene editing: an explainer

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

30 years of 'Listening to Prozac'

knowledge

entertainment

knowledge

ChatGPT in medicine: STAT answers readers' burning questions

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Hollywood unions extend contract negotiations for actors

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Medicare details structure of new drug price negotiation program

Cigna, Humana reportedly in talks to merge

Affirmative action in medical school literally saved lives

The EPA's new lead rule: How one expert crunched the numbers

Walensky prepares to leave CDC — and Congress — behind

J&J to emphasize cancer drugs, stop much of its vaccine research

focus

Rep. Raul Ruiz on the physician shortage and more

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Rep. Raul Ruiz on the physician shortage and more

Alabama IVF ruling threatens families facing fatal genetic disease

Will the market for weight loss drugs really reach $100 billion?

Diagnostic tests are hitting their mathematical limits

explore

knowledge

entertainment

hotspot